Saw Palmetto for Benign Prostatic Hyperplasia
Top Cited Papers
Open Access
- 9 February 2006
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 354 (6) , 557-566
- https://doi.org/10.1056/nejmoa053085
Abstract
Saw palmetto is used by over 2 million men in the United States for the treatment of benign prostatic hyperplasia and is commonly recommended as an alternative to drugs approved by the Food and Drug Administration.Keywords
This publication has 23 references indexed in Scilit:
- Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptomsUrology, 2001
- Wirksamkeit eines Sabal-Urtica-Kombinationspräparats bei der Behandlung der benignen Prostatahyperplasie (BPH)Der Urologe B, 1996
- Phytotherapy in treatment of benign prostatic hyperplasia: a critical reviewUrology, 1996
- Placebo-Controlled Evaluation of the Efficacy and Tolerability of Permixon® in Benign Prostatic Hyperplasia after Exclusion of Placebo RespondersClinical Drug Investigation, 1995
- Treatment of Benign Prostatic Hyperplasia with PhytosterolsBritish Journal of Urology, 1990
- The Value of Permixon in Benign Prostatic HypertrophyBritish Journal of Urology, 1986
- A double‐blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia.British Journal of Clinical Pharmacology, 1984
- Confronto Fra Estratto Di Serenoa Repens E Placebo Mediante Prova Clinica Controllata in Pazienti Con Adenomatosi ProstaticaUrologia Journal, 1983
- Risultati Clinici Su Un Nuovo Farmaco Nella Terapia Dell'Ipertrofia Della Prostata (Permixon)Urologia Journal, 1983
- Terapia Medica Dell'Adenoma Prostatico: Confronto Della Efficacia Dell'Estratto Di Serenoa Repens (Permixon®) versus L'Estratto Di Pigeum Africanum E Placebo: Valutazione in Doppio CiecoUrologia Journal, 1983